St. Louis-based developer **SentiAR** has gained 510(k) clearance from the U.S. Food and Drug Administration for its electrophysiology (EP) cardiac mapping system interface, CommandEP. This technology utilizes augmented reality to produce real-time 3D digital models of the heart, giving physicians a comprehensive 360-degree interactive guide during procedures, notably cardiac ablation. Through a headset, doctors can explore the holographic heart model, accessing detailed patient-specific information without interrupting the surgery’s sterile environment. Currently in use at Massachusetts General Hospital, the system has received positive feedback for its ability to enhance navigation efficiency during surgeries. Last year, SentiAR’s augmented reality technology underwent a peer-reviewed analysis, with full clinical case studies expected to be published later this year.
https://healthimaging.com/topics/cardiac-imaging/augmented-reality-cardiac-imaging-sentiar